Brief: ASGN Q3 Adjusted EPS USD 1.43 Vs. IBES Estimate USD 1.36
Oct 23 (Reuters) - ASGN Q3 adjusted EBITDA USD 116.9 million vs. IBES estimate USD 116.8 million. * Q3 adjusted EBITDA margin 11.3% * Q3 operating income USD 78.9 million * Q3 revenue USD 1,031 million vs. IBES estimate USD 1,034 million * Q3 adjusted net income USD 64.3 million vs. IBES estimate USD 61.5 million
Recent news on Everforth
See all newsU.S. RESEARCH ROUNDUP-Autodesk, Dell Technologies, Hyatt Hotels
U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks
U.S. STOCKS ON THE MOVE- American Airlines, Pot stocks, Paramount Skydance
ASGN plummets after weak Q2 forecast; brokerages cut PT
Brief: Asgn Incorporated To Change Corporate Name And NYSE Ticker To Everforth